Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68 Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection-Reference-Cited by-同舟云学术

Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68 Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection

Published:2020-04-23 Issue:6 Volume:125 Page:876-883
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Huits Thijs H.¹,Luiting Henk B.²^ORCID,van der Poel Henk G.¹^ORCID,Nandurkar Rohan³^ORCID,Donswijk Maarten⁴,Schaake Eva⁵,Vogel Wouter⁴⁵,Roobol Monique J.²^ORCID,Wit Esther¹,Stricker Phillip⁶⁷^ORCID,Emmett Louise³⁷,van Leeuwen Pim J.¹^ORCID

Affiliation:

1. Department of Urology; Netherlands Cancer Institute; Amsterdam The Netherlands

2. Department of Urology; Erasmus Medical Centre; Rotterdam The Netherlands

3. St Vincent's Hospital Nuclear Medicine and PET Department; Darlinghurst NSW Australia

4. Department of Nuclear Medicine; Netherlands Cancer Institute; Amsterdam The Netherlands

5. Department of Radiation Oncology; The Netherlands Cancer Institute; Amsterdam The Netherlands

6. St. Vincent's Prostate Cancer Centre; Darlinghurst NSW Australia

7. Garvan Institute of Medical Research; Darlinghurst NSW Australia

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.15052/fullpdf

Reference21 articles.

1. Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients;Gandaglia;Eur Urol,2017

2. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy;Briganti;Eur Urol,2014

3. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years;Suardi;Eur Urol,2015

4. Salvage lymph node dissection for nodal recurrence of prostate cancer after radical prostatectomy;Tilki;J Urol.,2015

5. Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy;Kaplan;BJU Int,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluación de la tasa de detección de la recidiva local y de cuerpo completo mediante la valoración integrada de la PET/RM con [18F]F-PSMA-1007 de pacientes con cáncer de próstata tratados con prostatectomía con recidiva bioquímica muy baja (< 0,5 ng/ml). Implicaciones terapéuticas;Revista Española de Medicina Nuclear e Imagen Molecular;2024-09

2. To evaluate the detection rate of local and whole-body recurrence by integrated [18F]F-PSMA-1007 PET/MR assessment of prostate cancer patients treated with prostatectomy with very low biochemical recurrence (<0.5 ng/ml). Therapeutic implications;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2024-09

3. Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography;European Urology Open Science;2024-03

4. 68Ga-PSMA-11 PET/CT versus 68Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-08-14

5. Prostate Cancer;Target Volume Definition in Radiation Oncology;2023